Synthesis and biological evaluation of platensimycin analogs.
Shen, H.C., Ding, F.X., Singh, S.B., Parthasarathy, G., Soisson, S.M., Ha, S.N., Chen, X., Kodali, S., Wang, J., Dorso, K., Tata, J.R., Hammond, M.L., Maccoss, M., Colletti, S.L.(2009) Bioorg Med Chem Lett 19: 1623-1627
- PubMed: 19233644 
- DOI: https://doi.org/10.1016/j.bmcl.2009.02.006
- Primary Citation of Related Structures:  
3G0Y, 3G11 - PubMed Abstract: 
Platensimycin (1) displays antibacterial activity due to its inhibition of the elongation condensing enzyme (FabF), a novel mode of action that could potentially lead to a breakthrough in developing a new generation of antibiotics. The medicinal chemistry efforts were focused on the modification of the enone moiety of platensimycin and several analogs showed significant activity against FabF and possess antibacterial activity.
Organizational Affiliation: 
Departments of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA.